The province of Quebec is moving forward with changes to its recreational cannabis market as it attempts to combat supply challenges.

On Tuesday (February 26), the Société québécoise du cannabis (SQDC) signed supply agreements with licensed producers (LPs) Organigram Holdings (TSXV:OGI,OTCQX:OGRMF) and Zenabis Global (TSXV:ZENA,OTC Pink:ZBISF) to add product to its lineup of recreational marijuana.


Both producers will have to wait for the public process of the SQDC to determine the exact start date and final agreement in terms of quantity sold to the province.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Zenabis informed shareholders it expects to supply product starting the second quarter of 2019.

This agreement for both marijuana firms represents an increase in the presence of their products across Canada.

Thanks to the deal, Zenabis product will be available in nine provinces, while Quebec was the last province missing in Organigram’s portfolio.

“This relationship represents an additional significant relationship with a provincial counterparty,” Andrew Grieve, CEO of Zenabis, said in a press release.

Organigram indicated it plans to supply Quebec with “mainstream, value and premium flower, along with an assortment of pre-rolls and oils.”

Greg Engel, Organigram’s CEO, said his company would build on the relationship with provincial bodies as “we look ahead to the legalization of cannabis edibles.”

Shares of Zenabis closed on Tuesday at a price of C$3.68, while Organigram finished the day priced at C$8.53.

On Wednesday, share prices for both producers declined with Organigram decreasing 2.23 percent for a price of C$8.34 and Zenabis dropping 0.27 percent for a finishing price of C$3.67.

Quebec adjusts restrictions on marijuana shops

Quebec implemented for its government-run stores to be closed three days a week in order to maintain its supply of recreational product.

On Tuesday, CBC reported the province had reduced this restriction to two days.

“We know that we are now capable of opening all the stores another day in the week because we know that our supply logistics can sustain the whole network,” SQDC spokesperson Fabrice Giguère said.

At the end of January, the SQDC reported it had sold 5.7 tonnes of legal cannabis, resulting in C$40 million during its first three months of sales.

“To diversify its pool of suppliers, the SQDC issued a call for tenders for products in December and is studying the bids received,” the provincial agency informed consumers. “That said, no significant increase in supply will occur before late spring 2019.”

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Ayurcann (CSE:AYUR) entered into a joint venture with Bazelet Group, Israel’s largest privately held medical cannabis company. Ayurcann CEO Igal Sudman shared the company’s excitement about bringing unique terpene-enriched medicinal cannabis to the Canadian marketplace. 

“Canada is a very closed-loop country, and the opportunity to bring a variety of different enhancement and technologically advanced products is very important to us. The relationship that we formed with Bazelet is going to enhance our offerings into the Canadian marketplace,” Sudman said. 

Bazelet has launched multiple lines of terpene-enriched cannabis oils; each one is specifically designed for various indications, symptoms and personal needs. The company’s terpene-enriched products are optimized for women’s health, for elderly population needs, for specific types of pains (muscle, joint, neuropathic) and for improved night sleep. 

According to Sudman, there are a lot of larger companies that have tried to do this, but none have been able to successfully bring innovation into the market. Ayurcann is rapidly forging partnerships with several companies worldwide, including Cannmart, Patient Choice and Kindred Partners.

“We’re growing the business, customer base, relationships and partnerships worldwide. We’re bringing the latest technology into Canada, and enhancing not only our company, but the investors’ value moving forward,” added Sudman. 

Watch the full interview with Ayurcann CEO Igal Sudman above.

Keep reading... Show less

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a new Florida dispensary, the Company’s 91st nationwide.

The latest dispensary, located in Winter Park , supports Trulieve’s goal of ensuring medical cannabis patients across Florida have safe, reliable access to the medications they rely on. The dispensary expands access throughout Central Florida , joining four locations throughout nearby Orlando .

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), the world’s most innovative cannabis extractor, is pleased to announce that the United States Patent and Trademark Office has granted the Company a patent pertaining to the extraction and purification of THC and CBD.

The Company believes it has developed defendable intellectual property around the most efficient methods for producing THC and CBD distillate at scale within a regulated market. Nextleaf owns 15 U.S. patents and has been issued over 80 patents globally.

Keep reading... Show less

Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com

Virtual Investor Conferences in partnership with KCSA Strategic Communications and ATB Capital Markets today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors, institutional investors, advisors and analysts are invited to attend. The two-day program begins at 9:30 AM ET on Tuesday June 29 th .

Keep reading... Show less

Acquisition solidifies Canopy Growth’s leadership position in the Canadian recreational market

Canopy Growth Corporation (“Canopy”) (TSX: WEED) (NASDAQ: CGC) and The Supreme Cannabis Company, Inc. (“Supreme”) (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) are pleased to announce the completion of the previously announced arrangement (the “Arrangement”) whereby Canopy has acquired all of the issued and outstanding common shares of Supreme (the “Supreme Shares”).

Keep reading... Show less